As for doses, this is dose-dependent , especially for resting energy expenditure (RMR) and respiratory quotient (RQ)*, which can lead to greater fat oxidation, as shown in the work of Rondanelli et al
Future studies should clarify the role of immune priming in modulating behavioral responses to antibiotic-induced gutbrain effects
Heterogenous impairment of cell function in type 2 diabetes is linked to cell maturation state
Ongoing research is critical to understanding the long-term effects of these treatments and optimizing their use in diverse patient populations
In the UK, semaglutide (Ozempic) and liraglutide (Victoza) are MHRA-approved for type 2 diabetes, while semaglutide (Wegovy) and liraglutide (Saxenda) are specifically licensed for weight management
The effect is dose-dependent: higher doses produce stronger GI slowing, explaining why gas symptoms often peak during dose escalation